Relationship between Quality of Life and Nurse-led Bedside Symptom Evaluations in Patients with Chemotherapy-induced Peripheral Neuropathy.
- Author:
Yang Sook YOO
1
;
Ok Hee CHO
Author Information
1. College of Nursing, The Catholic University, Seoul, South Korea.
- Publication Type:Original Article ; Research Support, Non-U.S. Gov't
- Keywords:
neurotoxicity syndromes;
quality of life;
symptom assessment
- MeSH:
Aged;
Antineoplastic Agents/adverse effects;
*Attitude of Health Personnel;
Cross-Sectional Studies;
Female;
Humans;
Male;
Middle Aged;
Neoplasms/drug therapy;
Neurotoxicity Syndromes/*diagnosis/etiology;
Nurses/*psychology;
Peripheral Nervous System Diseases/chemically induced/*diagnosis;
Platinum Compounds/adverse effects;
*Quality of Life;
Questionnaires;
Symptom Assessment/methods/*standards;
Taxoids/adverse effects
- From:Asian Nursing Research
2014;8(1):36-41
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: This cross-sectional study aimed at determining the relationship between patient-reported quality of life (QOL) and nurse-led bedside evaluations of chemotherapy-induced peripheral neuropathy symptoms. METHODS: One hundred ninety-five patients treated at the oncology clinic at our institution were assessed using Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity and nurse-led bedside examinations. The relationship between self-reported QOL and bedside examinations was evaluated using Spearman rank correlations. RESULTS: Scores of upper and lower extremity muscle strength based on the bedside examinations showed a weak negative correlation with the emotional well-being subscale of Functional Assessment of Cancer Therapy-General. Further, weak negative relationships were present between QOL and the following nurse-reported parameters: vibration perception in the hand, upper extremity muscle strength, touch and vibration perception in the feet, and tendon reflexes. CONCLUSION: Collectively, our results indicate that nurse-led bedside evaluation is a noninvasive and useful method for detecting neurotoxicity and evaluating the patient's QOL both during and after treatment.
